MyBiotech has deep expertise in developing both oral and parenteral dosage forms from early feasibility studies to formulation optimization and clinical manufacturing. Our teams work across small molecules, biologics, and complex APIs to create stable, scalable, and high-performance drug products tailored to your delivery route. Our services with scalability in mind—combining feasibility studies, formulation screening, analytical development and characterization. Whether your goal is improved solubility, controlled release, enhanced bioavailability, or stable injectables, MyBiotech provides end-to-end CDMO support including: - Preformulation and feasibility studies - Process development - Formulation screening and formulation optimization - Scale up and process development - Clinical manufacturing (GMP) - Analytical development & stability studies Our integrated approach reduces development timelines and ensures consistent, scalable results from early R&D to clinical supply. With MyBiotech, you gain a development partner who combines scientific depth with the speed and flexibility required in dynamic nanomedicine development ecosystem. MyBiotech integrates R&D, scale-up, analytical development, stability testing, and GMP manufacturing including aseptic fill-and-finish—all under one roof. This unified CDMO structure enables: Faster development timelines Reduced project risk A smoother and more predictable path from concept to first-in-human studies
